Pharma News, 2019

Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers since they rarely have early symptoms.

Amarin has been riding high on hopes for its heart drug Vascepa, and it's planning a $400 million stock offering to make the most of it.

(Reuters) - Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.

A team of scientists led by EMBL group leader Sagar Bhogaraju and Ivan Dikic of Goethe University, Frankfurt, discovered that the toxin SidJ in Legionella bacteria enforces a unique modification on hu...

Big Pharma has bitterly fought against being forced to pay for drug recycling, but another part of the industry has taken it up.

NORTH CHICAGO, Ill.

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical have entered into a clinical collaboration to evaluate the combination of Stivarga (regorafenib) with Opdivo (nivolumab) in patients ...

A team from The University of Manchester have engineered a common gut bacterium to produce a new class of antibiotics by using robotics.

A powerful bee sting vaccine designed to eliminate the risk of a severe allergic reaction to European honeybee venom has successfully completed a human trial in South Australia.

As cancer cells progress, they accumulate hundreds and even thousands of genetic and epigenetic changes, resulting in protein expression profiles that are radically different from that of healthy cell...

The art of tattooing may have found a diagnostic twist.

A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients.